Table 1 The characteristics of the patients (n = 117)
From: Serum myokine (myostatin and IGF-1) measurement as predictors in hemodialysis patients
| Age, years | 58.9 ± 12.1 |
| Male to female | 76:41 |
| Dialysis vintage, years | 8.67 ± 8.1 |
| Cause of renal failure, n | |
| CGN | 62 (53%) |
| DN | 39 (33%) |
| RPGN | 2 (2%) |
| PKD | 3 (3%) |
| Others | 11 (9%) |
| Alb, g/dL | 3.85 ± 0.24 |
| BUN, mg/dL | 74.1 ± 17.0 |
| Creatinine, mg/dL | 11.5 ± 2.79 |
| Calcium, mg/dL | 9.16 ± 0.96 |
| Phosphorus, mg/dL | 5.93 ± 1.48 |
| Total cholesterol, mg/dL | 157 ± 36 |
| LDL, mg/dL | 92.1 ± 27.2 |
| HDL, mg/dL | 44 ± 15 |
| Triglyceride, mg/dL | 103 ± 72 |
| Myostatin, pg/mL | 5424 ± 2887 |
| IGF-1, ng/mL | 156.8 ± 70.7 |
| Drugs, n | |
| ARB | 58 (50%) |
| ACEi | 3 (3%) |
| Calcium blocker | 71 (61%) |
| Vit. D | 81 (69%) |
| Statin | 10 (9%) |
| Kt/V | 1.36 ± 0.24 |
| PCR, g/kg/day | 0.83 ± 0.21 |